EUVIMEDEUVIMED entdecken
Crossref

An ACE2, SARS-CoV-2 spike protein binding protein, -like enzyme isolated from food-related microorganisms

Izza Nur Laily, Michiki Takeuchi iD, Taku Mizutani, Jun Ogawa

Bioscience, Biotechnology, and Biochemistry · 2023

DOI: 10.1093/bbb/zbad037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2023. Verfasst von Izza Nur Laily und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Applied Life Science, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto, Japan. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: New Energy and Industrial Technology Development Organization, Ministry of Health and Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiotensin-converting enzyme 2 (ACE2) is a binding target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. An ACE2-like enzyme, such as bacterial M32-carboxypeptidase (M32-CAP), is assumed to be a potential therapeutic candidate for coronavirus disease 2019 (COVID-19). Here, we screened bacteria with an ACE2-like enzyme activity from Japanese fermented food and dietary products using the fluorogenic substrate for rapid screening. The strain showing the highest activity, Enterobacter sp. 200527-13, produced an enzyme with the same hydrolytic activity as ACE2 on Angiotensin II (Ang II). The enzymatic analysis using the heterologously-expressed enzyme in Escherichia coli revealed that the enzyme catalyzes the same reaction with that of ACE2, Ang II hydrolysis to Ang 1-7, and phenylalanine. The gene sequence information showed that the enzyme belongs to the M32-CAP family. These results suggested that the selected enzyme, M32-CAP (EntCP), from Enterobacter sp. 200527-13 was identified as an ACE2-like enzyme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase ACarrier ProteinsProtein Binding

Stichwörter der Autor:innen

enterobacter spACE2M32-carboxypeptidaseSARS-CoV-2

Substanzen

spike protein, SARS-CoV-2Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase ACarrier Proteins

Autor:innen und Institutionen

  • Division of Applied Life Science, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto, Japan.
  • Department of Biology, School of Life Science and Technology, Bandung Institute of Technology (ITB), Bandung, Indonesia.
  • Industrial Microbiology, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto, Japan.

ORCID-Profile: Michiki Takeuchi

Förderung

  • New Energy and Industrial Technology Development Organization
  • Ministry of Health and Welfare of Japan

Zitieren

APA

Laily, I. N., Takeuchi, M., Mizutani, T., & Ogawa, J. (2023). An ACE2, SARS-CoV-2 spike protein binding protein, -like enzyme isolated from food-related microorganisms. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbad037

Vancouver

Laily IN, Takeuchi M, Mizutani T, Ogawa J. An ACE2, SARS-CoV-2 spike protein binding protein, -like enzyme isolated from food-related microorganisms. Bioscience, Biotechnology, and Biochemistry. 2023. doi:10.1093/bbb/zbad037

BibTeX
@article{Laily2023,
  author = {Laily, Izza Nur and Takeuchi, Michiki and Mizutani, Taku and Ogawa, Jun},
  title = {An ACE2, SARS-CoV-2 spike protein binding protein, -like enzyme isolated from food-related microorganisms},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2023},
  doi = {10.1093/bbb/zbad037}
}
Kostenlos starten →